Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.

Voronova A, Gallagher D, Zander M, Cancino G, Bramall A, Krause MP, Abad C, Tekin M, Neilsen PM, Callen DF, Scherer SW, Keller GM, Kaplan DR, Walz K, Miller FD.

Springerplus. 2015 Jun 12;4(Suppl 1):L28. doi: 10.1186/2193-1801-4-S1-L28. eCollection 2015. No abstract available.

2.

Ankrd11 is a chromatin regulator involved in autism that is essential for neural development.

Gallagher D, Voronova A, Zander MA, Cancino GI, Bramall A, Krause MP, Abad C, Tekin M, Neilsen PM, Callen DF, Scherer SW, Keller GM, Kaplan DR, Walz K, Miller FD.

Dev Cell. 2015 Jan 12;32(1):31-42. doi: 10.1016/j.devcel.2014.11.031. Epub 2014 Dec 31.

3.

A de novo microdeletion of ANKRD11 gene in a Korean patient with KBG syndrome.

Lim JH, Seo EJ, Kim YM, Cho HJ, Lee JO, Cheon CK, Yoo HW.

Ann Lab Med. 2014 Sep;34(5):390-4. doi: 10.3343/alm.2014.34.5.390. Epub 2014 Aug 21.

4.

Neurobehavioral phenotype observed in KBG syndrome caused by ANKRD11 mutations.

Lo-Castro A, Brancati F, Digilio MC, Garaci FG, Bollero P, Alfieri P, Curatolo P.

Am J Med Genet B Neuropsychiatr Genet. 2013 Jan;162B(1):17-23. doi: 10.1002/ajmg.b.32113. Epub 2012 Nov 26.

PMID:
23184435
5.

Partial deletion of ANKRD11 results in the KBG phenotype distinct from the 16q24.3 microdeletion syndrome.

Khalifa M, Stein J, Grau L, Nelson V, Meck J, Aradhya S, Duby J.

Am J Med Genet A. 2013 Apr;161A(4):835-40. doi: 10.1002/ajmg.a.35739. Epub 2013 Mar 12.

PMID:
23494856
6.

Identification of ANKRD11 as a p53 coactivator.

Neilsen PM, Cheney KM, Li CW, Chen JD, Cawrse JE, Schulz RB, Powell JA, Kumar R, Callen DF.

J Cell Sci. 2008 Nov 1;121(Pt 21):3541-52. doi: 10.1242/jcs.026351. Epub 2008 Oct 7.

7.

Chromatin regulators of neural development.

Tyssowski K, Kishi Y, Gotoh Y.

Neuroscience. 2014 Apr 4;264:4-16. doi: 10.1016/j.neuroscience.2013.10.008. Epub 2013 Oct 18. Review.

PMID:
24144622
8.

Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome.

Willemsen MH, Fernandez BA, Bacino CA, Gerkes E, de Brouwer AP, Pfundt R, Sikkema-Raddatz B, Scherer SW, Marshall CR, Potocki L, van Bokhoven H, Kleefstra T.

Eur J Hum Genet. 2010 Apr;18(4):429-35. doi: 10.1038/ejhg.2009.192. Epub 2009 Nov 18.

9.

Specific-site methylation of tumour suppressor ANKRD11 in breast cancer.

Lim SP, Wong NC, Suetani RJ, Ho K, Ng JL, Neilsen PM, Gill PG, Kumar R, Callen DF.

Eur J Cancer. 2012 Nov;48(17):3300-9. doi: 10.1016/j.ejca.2012.03.023. Epub 2012 Apr 24.

PMID:
22538187
10.

Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11.

Noll JE, Jeffery J, Al-Ejeh F, Kumar R, Khanna KK, Callen DF, Neilsen PM.

Oncogene. 2012 Jun 7;31(23):2836-48. doi: 10.1038/onc.2011.456. Epub 2011 Oct 10.

PMID:
21986947
11.

Roles of chromatin remodelers in maintenance mechanisms of multipotency of mouse trunk neural crest cells in the formation of neural crest-derived stem cells.

Fujita K, Ogawa R, Kawawaki S, Ito K.

Mech Dev. 2014 Aug;133:126-45. doi: 10.1016/j.mod.2014.05.001. Epub 2014 May 15.

12.

Familial 16q24.3 microdeletion involving ANKRD11 causes a KBG-like syndrome.

Sacharow S, Li D, Fan YS, Tekin M.

Am J Med Genet A. 2012 Mar;158A(3):547-52. doi: 10.1002/ajmg.a.34436. Epub 2012 Feb 3.

PMID:
22307766
13.

Transcription of genes encoding synaptic vesicle proteins in human neural stem cells: chromatin accessibility, histone methylation pattern, and the essential role of rest.

Ekici M, Hohl M, Schuit F, Martínez-Serrano A, Thiel G.

J Biol Chem. 2008 Apr 4;283(14):9257-68. doi: 10.1074/jbc.M709388200. Epub 2008 Jan 30.

14.

The chromatin remodeler CHD7 regulates adult neurogenesis via activation of SoxC transcription factors.

Feng W, Khan MA, Bellvis P, Zhu Z, Bernhardt O, Herold-Mende C, Liu HK.

Cell Stem Cell. 2013 Jul 3;13(1):62-72. doi: 10.1016/j.stem.2013.05.002.

15.

Feline bone marrow-derived mesenchymal stem cells express several pluripotent and neural markers and easily turn into neural-like cells by manipulation with chromatin modifying agents and neural inducing factors.

Zhang Z, Maiman DJ, Kurpad SN, Crowe MJ, Alexanian AR.

Cell Reprogram. 2011 Oct;13(5):385-90. doi: 10.1089/cell.2011.0007. Epub 2011 Jun 30.

PMID:
21718099
16.

Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation.

Qiao Y, Wang R, Yang X, Tang K, Jing N.

J Biol Chem. 2015 Jan 23;290(4):2508-20. doi: 10.1074/jbc.M114.603761. Epub 2014 Dec 17. Erratum in: J Biol Chem. 2015 Apr 17;290(16):9949.

17.

Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.

Natsume A, Ito M, Katsushima K, Ohka F, Hatanaka A, Shinjo K, Sato S, Takahashi S, Ishikawa Y, Takeuchi I, Shimogawa H, Uesugi M, Okano H, Kim SU, Wakabayashi T, Issa JP, Sekido Y, Kondo Y.

Cancer Res. 2013 Jul 15;73(14):4559-70. doi: 10.1158/0008-5472.CAN-13-0109. Epub 2013 May 29.

18.

Adaptor protein LNK is a negative regulator of brain neural stem cell proliferation after stroke.

Ahlenius H, Devaraju K, Monni E, Oki K, Wattananit S, Darsalia V, Iosif RE, Torper O, Wood JC, Braun S, Jagemann L, Nuber UA, Englund E, Jacobsen SE, Lindvall O, Kokaia Z.

J Neurosci. 2012 Apr 11;32(15):5151-64. doi: 10.1523/JNEUROSCI.0474-12.2012.

19.

The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells?

Pfannkuche K, Summer H, Li O, Hescheler J, Dröge P.

Stem Cell Rev. 2009 Sep;5(3):224-30. doi: 10.1007/s12015-009-9078-9. Epub 2009 Jun 24. Review.

PMID:
19551524
20.

Dual functions of hypoxia-inducible factor 1 alpha for the commitment of mouse embryonic stem cells toward a neural lineage.

Zhao Y, Matsuo-Takasaki M, Tsuboi I, Kimura K, Salazar GT, Yamashita T, Ohneda O.

Stem Cells Dev. 2014 Sep 15;23(18):2143-55. doi: 10.1089/scd.2013.0278. Epub 2014 Feb 7.

PMID:
24236637

Supplemental Content

Support Center